Total Payments
$7,772
2022 Payments
$7,190
Companies
10
Transactions
28
Medicare Patients
611
Medicare Billing
$79,017
Payment Breakdown by Category
Consulting$7,165 (92.2%)
Food & Beverage$593.02 (7.6%)
Education$14.13 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,165 | 8 | 92.2% |
| Food and Beverage | $593.02 | 18 | 7.6% |
| Education | $14.13 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $7,165 | 8 | $0 (2022) |
| Amarin Pharma Inc. | $331.39 | 7 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $110.46 | 1 | $0 (2017) |
| Genentech USA, Inc. | $69.27 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $30.71 | 2 | $0 (2017) |
| PFIZER INC. | $14.72 | 1 | $0 (2019) |
| Esperion Therapeutics, Inc. | $14.27 | 1 | $0 (2021) |
| Althera Pharmaceuticals LLC | $13.06 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.12 | 1 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $11.15 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $7,190 | 10 | Gilead Sciences, Inc. ($7,165) |
| 2021 | $66.21 | 5 | Genentech USA, Inc. ($29.41) |
| 2020 | $28.13 | 2 | Genentech USA, Inc. ($28.13) |
| 2019 | $148.99 | 3 | Amarin Pharma Inc. ($122.54) |
| 2017 | $338.64 | 8 | Amarin Pharma Inc. ($197.47) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $220.00 | General |
| 05/18/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $160.00 | General |
| 03/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: PRIMARY CARE | ||||||
| 03/02/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $360.00 | General |
| 02/23/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,955.00 | General |
| 02/23/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $360.00 | General |
| 02/23/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $335.00 | General |
| 01/26/2022 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular | ||||||
| 01/24/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 01/24/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| 12/02/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Virology & Specialty Care | ||||||
| 11/02/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Virology & Specialty Care | ||||||
| 07/13/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Sleep | ||||||
| 06/08/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiovascular | ||||||
| 05/20/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Virology & Specialty Care | ||||||
| 01/06/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Virology & Specialty Care | ||||||
| 02/26/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $122.54 | General |
| Category: Hypertriglyceridemia | ||||||
| 01/18/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Virology & Specialty Care | ||||||
| 10/25/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $137.66 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/25/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/28/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $110.46 | General |
| Category: DIABETES | ||||||
| 05/10/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/26/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 241 | 435 | $45,834 | $30,506 |
| 2022 | 8 | 135 | 240 | $29,974 | $19,413 |
| 2021 | 6 | 108 | 193 | $25,905 | $16,814 |
| 2020 | 6 | 127 | 200 | $21,721 | $12,284 |
Total Patients
611
Total Services
1,068
Medicare Billing
$79,017
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 147 | $31,346 | $20,310 | 64.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 41 | $6,253 | $4,194 | 67.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $3,494 | $2,972 | 85.1% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2023 | 22 | 22 | $974.12 | $646.80 | 66.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 17 | $768.67 | $588.54 | 76.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 36 | $595.80 | $583.92 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 32 | $825.27 | $366.30 | 44.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 21 | $348.11 | $327.94 | 94.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 28 | $710.00 | $235.20 | 33.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 28 | 44 | $353.71 | $173.36 | 49.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 25 | 25 | $165.12 | $107.25 | 65.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 98 | $21,758 | $13,476 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 29 | $4,584 | $2,926 | 63.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,266 | $1,937 | 85.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $361.30 | $356.16 | 98.6% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 11 | 11 | $512.05 | $330.84 | 64.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $286.84 | $183.64 | 64.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 23 | 35 | $140.70 | $138.74 | 98.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 15 | 15 | $65.70 | $64.55 | 98.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 81 | $17,794 | $11,182 | 62.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 33 | $5,113 | $3,365 | 65.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $2,098 | $1,841 | 87.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 19 | $588.71 | $231.48 | 39.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 22 | 32 | $190.60 | $128.64 | 67.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 15 | 15 | $121.32 | $65.70 | 54.2% |
About Dr. Maurizio Cervone, D.O
Dr. Maurizio Cervone, D.O is a Family Medicine healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174653331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maurizio Cervone, D.O has received a total of $7,772 in payments from pharmaceutical and medical device companies, with $7,190 received in 2022. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($7,165).
As a Medicare-enrolled provider, Cervone has provided services to 611 Medicare beneficiaries, totaling 1,068 services with total Medicare billing of $79,017. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Morris Plains, NJ
- Active Since 03/06/2007
- Last Updated 10/16/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174653331
Products in Payments
- Vascepa (Drug) $331.39
- JARDIANCE (Drug) $110.46
- Xofluza (Drug) $69.27
- SYMBICORT (Drug) $30.71
- COLOGUARD (Device) $14.72
- NEXLETOL (Drug) $14.27
- Roszet (Drug) $13.06
- NURTEC ODT (Drug) $12.12
- Horizant (Drug) $11.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Morris Plains
Dr. Charles Joseph, M.d, M.D
Family Medicine — Payments: $4,405
Family Medicine $4,405
Mrs. Maria Lijo, M.d, M.D
Family Medicine — Payments: $2,340
Family Medicine $2,340
Dr. Maria Tempera, D.o, D.O
Family Medicine — Payments: $643.93
Family Medicine $643.93
Marc Cadet, Md, MD
Family Medicine — Payments: $23.96
Family Medicine $23.96
Oswald Andre, M.d, M.D
Family Medicine
Family Medicine
Oswald Cervone, Do, DO
Family Medicine
Family Medicine